Chia‐Jung Li - Publications, H-index & Citations

Chia‐Jung Li

Cheng Shiu University

37H指数

230论文数

5.4K被引数

收录论文 111

发表时间

Reproducibility-driven clinical translation of spatial multi-omics in precision medicine 以可重复性驱动的空间多组学在精准医学中的临床转化

Journal of Translational Medicine

IF7.5

2026-09-16

OAAI

Tzu-Hung Hsiao; Chen-Yueh Wen; Yu-Ting Kang; Andy P. Tsai; Boyang Wang; Chia-Ying Li; Chia-Jung Li

Clonal Mosaicism of Mitochondrial DNA Heteroplasmy as a Molecular Clock of Aging 线粒体DNA异质性克隆镶嵌体作为衰老的分子钟

Aging Cell

IF7.1

2026-09-12

OAAI

Renin Chang; Andy P. Tsai; Boyang Wang; Kuan-Hao Tsui; Cheng-Yoong Pang; Chia-Jung Li

Assembling Power: A Mitochondrial Supercomplex Fuels Metastasis 组装动力：一种线粒体超级复合物驱动转移

Cancer Letters

IF10.1

2026-08-25

PREAI

Tzu-Hung Hsiao; Yu-Ting Kang; Yen-Dun Tony Tzeng; Chia-Jung Li

Targeting Ferroptosis Dependency as a New Senolytic Frontier 靶向铁死亡依赖性作为新的清除衰老细胞的前沿

Cancer Letters

IF10.1

2026-08-14

PREAI

Yen-Dun Tony Tzeng; Jui-Hu Hsiao; Chia-Jung Li

Frontline Immunotherapy and Immune Cold Reprogramming Across Molecular Subtypes of Advanced Endometrial Cancer 一线免疫治疗和免疫冷转暖重编程在高级别子宫内膜癌分子亚型间的应用

Cancer Letters

IF10.1

2026-06-04

OAAI

Pei-Hsuan Lin; Shih-Hsuan Cheng; Emmanuel Naveen Raj; Zhi-Hong Wen; Jim Jinn-Chyuan Sheu; Renin Chang; An-Jen Chiang; Chia-Jung Li

CAR-T Therapies and Emerging Alternatives: Reassessing Cost-Effectiveness and Future Directions in Modern Immunotherapy CAR-T疗法与新兴替代方案：重新评估现代免疫疗法中的成本效益和未来方向

International Journal of Rheumatic Diseases

IF2

2026-04-24

PREAI

Wang, Yen-Cheng; Li, Chia-Jung; Yong, Su-Boon; Shih, Po-Cheng

Identification of novel biomarkers and drug targets for frailty-related skeletal muscle aging: a multi-omics study correspondence 鉴定与衰弱相关骨骼肌衰老的新型生物标志物和药物靶点：一项多组学研究通讯

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

IF6.4

2026-04-01

PREAI

Tsai, Ya-An; Wang, Chen-Yu; Chen, Hsin-Jou; Liu, Xiao-Ling; Yong, Su-Boon; Li, Chia-Jung

Progesterone and suicidality in male combat veterans-correspondence 孕酮与男性战斗退伍军人的自杀行为——通讯

QJM: An International Journal of Medicine

IF0

2026-03-15

PREAI

Siao-Jhen Yan; Si-Ru Kao; Sheng-Yu Wu; Shang-Yuan Lin; Su-Boon Yong; Chia-Jung Li; Xiao-Ling Liu

Mitochondrial Energy Metabolism as a Regulator of Immune-Related Diseases 线粒体能量代谢作为免疫相关疾病的调控因子

International Journal of Rheumatic Diseases

IF2

2026-03-09

PREAI

Yong, Su-Boon; Chen, Po-Hung; Wu, Meng-Yu; Li, Chia-Jung; Wei, James Cheng-Chung

The Effectiveness of Virtual Reality Air-to-Ground Handoff Education in Realistic Operations on Learning Among Emergency Nurses in Taiwan 虚拟现实空对地交接教育在真实操作中对台湾急诊护士学习效果的影响

Journal of Nursing Management

IF4

2026-03-06

OAAI

Yu-Shan Chou; Hon-Ping Ma; Chu-Yu Huang; Chia-Jung Li; Li-Ying Chou; Su-Fen Cheng

ATP synthasome contributes to efficient energy flux in malignant breast cancer ATP synthasome有助于恶性乳腺癌的高效能量流动。

Molecular Cancer

IF33.9

2026-03-02

OAAI

Yen-Dun Tony Tzeng; Yu-Ting Kang; Tzu-Hung Hsiao; Pei-Yi Chu; Su-Boon Yong; Shih-Chieh Lin; Meng-Yu Wu; Ling-Ming Tseng; Ming-Feng Hou; Zhi-Hong Wen; Tzu-Sheng Hsu; Chih-Chiang Hung; An-Jen Chiang; Kuan-Hao Tsui; Chia-Jung Li

Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation 2型糖尿病中SGLT2抑制剂与GLP-1受体激动剂对肾癌和尿路上皮癌风险的比较：一项目标试验模拟研究

Nephrology Dialysis Transplantation

IF5.6

2026-03-01

PREAI

Huang, Chien-Wei; Lai, Edward Chia-Cheng; Wu, Vin-Cent; Hsieh, Miyuki Hsing-Chun; Li, Chia-Jung; Chang, Renin; Chen, Jin-Shuen; Tsai, Yau-Sheng; Sung, Junne-Ming

Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy 靶向GCN5介导的ERK乳酰化：癌症治疗中一个有前景的药物开发前沿

Biomedicine & Pharmacotherapy

IF7.5

2026-02-21

OAAI

Yen-Dun Tony Tzeng; An-Jen Chiang; Chia-Jung Li

Spatially gated oxidative killing: mitoxyperilysis redefines how ROS cause lytic cell death 空间门控氧化性杀伤：Mitoxyperilysis重新定义了ROS如何导致裂解性细胞死亡

Apoptosis

IF8.1

2026-02-20

PREAI

Meng-Yu Wu; Andy P. Tsai; Su-Boon Yong; Chia-Jung Li